BioSpace News Archive

Biotech Bay

Aligos Therapeutics Begins Dosing with Antisense Oligonucleotide Drug Candidate, ALG-020572, in Healthy Volunteers in a Phase 1 Proof-of-Concept Study

Aligos Therapeutics, Inc. today announced that the company has started dosing in the first cohort of healthy volunteers in Study ALG-020572-401 (NCT05001022).

October 11, 2021
·
5 min read
Drug Development

Reistone Announces Positive Results from a Phase II Study Evaluating SHR0302 Ointment for Patients with Mild-to-Moderate Atopic Dermatitis

Reistone Biopharma today announced positive results from a Phase II study evaluating the safety and efficacy of twice daily SHR0302 ointment in adults and adolescents with mild-to-moderate atopic dermatitis (AD).

October 11, 2021
·
4 min read
Drug Development

INOVIO Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate for COVID-19, to include Colombia following Regulatory Authorization

Authorization to conduct INNOVATE Phase 3 in Colombia builds on recent regulatory authorizations from Brazil, Philippines, and Mexico

October 11, 2021
·
7 min read
Pharm Country

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference.

October 11, 2021
·
3 min read
Drug Development

SCYNEXIS Announces Preclinical Data at the 10th Trends in Medical Mycology Meeting Supporting Potential of Ibrexafungerp to Treat Mucormycosis

SCYNEXIS, Inc. today announced the presentation of preclinical data supporting the potential of its broad-spectrum antifungal, ibrexafungerp, to treat mucormycosis.

October 11, 2021
·
6 min read
Business

Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy

The Twist Alliance Pan-Cancer Methylation Panel was launched globally on September 24th (US time).

October 11, 2021
·
5 min read
Policy

Kintor Pharma Announces China NMPA Approves Clinical Trial of ALK-1 and Nivolumab Combination Therapy for the First-line Treatment of Advanced Hepatocellular Carcinoma

Kintor Pharmaceutical Limited announced that the clinical trial of ALK-1 antibody and Nivolumab combination therapy for the treatment of systemic therapy naïve patients with advanced hepatocellular carcinoma was approved by the National Medical Products Administration of China on October 9, 2021.

October 11, 2021
·
2 min read
Peptic Ulcers Drugs Market to receive overwhelming hike in Revenues by 2030

Sores that develop on the lining of stomach, esophagus, and intestines are called peptic ulcers. Symptoms of peptic ulcers include vomiting, burning stomach pain, bloating, and food intolerance.

October 11, 2021
·
5 min read
Newborn Screening Market: Dry Blood Spot Test to be Highly Lucrative Test Type

According to the report, the global newborn screening market was valued at ~US$ 940 Mn in 2019 and is projected to expand at a CAGR of ~11% from 2021 to 2031.

October 11, 2021
·
6 min read
Dermal Fillers Market: Hyaluronic Acid Segment to Expand at a Robust CAGR

Transparency Market Research has Published a new report titled, “Dermal Fillers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

October 11, 2021
·
7 min read